A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/195 (2006.01) A61K 31/70 (2006.01) A61K 38/48 (2006.01) A61K 47/48 (2006.01) C07K 14/71 (2006.01) C12N 9/12 (2006.01) C12N 9/48 (2006.01)
Patent
CA 2196052
The invention provides a two-component system for gene-directed enzyme prodrug therapy which comprises: (a) a vector which encodes a carboxypeptidase which is expressed within a cell; and (b) a prodrug which can be converted into an active drug by said carboxypeptidase, useful in the treatment of tumours.
Système à deux constituants pour une thérapie génique à base de promédicament et d'enzyme, comprenant: (a) un vecteur qui code une carboxypeptidase exprimée à l'intérieur d'une cellule et (b) un promédicament qui peut être converti en un médicament actif par ladite carboxypeptidase, utile dans le traitement des tumeurs.
Marais Richard
Springer Caroline Joy
Cancer Research Campaign Technology Limited
Mccarthy Tetrault Llp
LandOfFree
Intracellular expression of carboxypeptidase g2 in enzyme... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular expression of carboxypeptidase g2 in enzyme..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular expression of carboxypeptidase g2 in enzyme... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1889249